Results 101 to 110 of about 117,976 (202)

Exenatide extended-release; clinical trials, patient preference, and economic considerations

Patient Preference and Adherence, 2013
Sheila A DoggrellSchool of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, AustraliaAbstract: Type 2 diabetes remains an escalating problem worldwide, despite a range of treatments being available.
Doggrell SA
doaj  

Glucagon-like peptide-2 protects the gastric mucosa via regulating blood flow and metabolites. [PDF]

Front Endocrinol (Lausanne), 2022
Zhang J, Ning J, Hao X, Han X, Fu W, Gong Y, Meng Q, Ding S, Zhang J.   +8 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and cardiometabolic protection: historical development and future challenges

Cardiovascular Diabetology
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized the treatment of cardiometabolic diseases, extending their therapeutic applications far beyond glycemic control in type 2 diabetes (T2D) and obesity.
Francisco Westermeier, Enrique Z. Fisman
doaj   +1 more source

Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure. [PDF]

World J Gastroenterol, 2022
Pizzoferrato M, Puca P, Ennas S, Cammarota G, Guidi L.   +4 more
europepmc   +1 more source

Glucagon-like Peptide 2 (GLP-2) [PDF]

, 2004
Julie Lovshin, Daniel J. Drucker
openaire   +1 more source

Conformational Dynamics of Glucagon-like Peptide-2 with Different Electric Field. [PDF]

Polymers (Basel), 2022
Su J, Sun T, Wang Y, Shen Y.
europepmc   +1 more source

Expression of neurogenin3 reveals an islet cell precursor population in the pancreas [PDF]

, 2000
Differentiation of early gut endoderm cells into the endocrine cells forming the pancreatic islets of Langerhans depends on a cascade of gene activation events controlled by transcription factors including the basic helix-loop-helix (bHLH) proteins.
Anderson, David J., Conners, Jennifer R., German, Michael S., Johnson, Jeffrey D., Kalamaras, Julie, Lee, Jacqueline E., Scheel, David W., Schwitzgebel, Valérie M., Sussel, Lori   +8 more
core  

Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects. [PDF]

Clin Drug Investig, 2022
Agersnap MA, Sonne K, Knudsen KM, Knudsen CB, Berner-Hansen M.   +4 more
europepmc   +1 more source

Glucose and Several Mitogenic Agents Modulate the Glucagon-Like Peptide-2 Receptor Expression in Cultured Rat Astrocytes. [PDF]

J Alzheimers Dis Rep, 2022
Velázquez E, Le Baut Ayuso Y, Blázquez E, Ruiz-Albusac JM.   +3 more
europepmc   +1 more source

Population profile and glycemic control following initiation or switch of injectable therapies in Tianjin, China: A real‐world retrospective cohort study of adults with type 2 diabetes

Journal of Diabetes Investigation
Aims To evaluate characteristics and glycemic outcomes in individuals with type 2 diabetes using injectable therapies in real‐world clinical practice in Tianjin, China.
Qiumei Zhang, Yaqing Fan, Xixi Liu, Minlu Zhang, Jiewen Zhang, Qin Du, Lei Kang, Liming Chen   +7 more
doaj   +1 more source